Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase

[Image: see text] The Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase associated with various kinds of leukemia and solid tumors. Thus, there is substantial interest in developing SHP2 inhibitors as potential anticancer and antileukemia agents. Usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Li-Fan, Zhang, Ruo-Yu, Yu, Zhi-Hong, Li, Sijiu, Wu, Li, Gunawan, Andrea M., Lane, Brandon S., Mali, Raghuveer S., Li, Xingjun, Chan, Rebecca J., Kapur, Reuben, Wells, Clark D., Zhang, Zhong-Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136714/
https://www.ncbi.nlm.nih.gov/pubmed/25003231
http://dx.doi.org/10.1021/jm5006176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136714/
https://www.ncbi.nlm.nih.gov/pubmed/25003231
http://dx.doi.org/10.1021/jm5006176

Ejemplares similares